2.508 The HMG-CoA reductase inhibitor lovastatin reduces incidence of L-Dopa-induced abnormal involuntary movements in experimental Parkinson's disease

✍ Scribed by S. Schuster; A. Nadjar; J.T. Guo; Q. Li; C. Ittrich; B. Hengerer; E. Bezard

• Book ID: 117753022
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 53 KB
• Volume: 13
• Category: Article
• ISSN: 1353-8020
• DOI: 10.1016/s1353-8020(08)70782-x